Botai Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Cancer-related gene regulation
Papers in ⓘ
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 3
- ATP Synthase and ATPases Research 2
- Steroid Chemistry and Biochemistry 1
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Haojie Jin (6 shared papers)Chengtao Yu (6 shared papers)Wenxin Qin (7 shared papers)Zhuoan Cheng (5 shared papers)Chen Yang (4 shared papers)Siying Wang (4 shared papers)Yuanyuan Lv (4 shared papers)Qiaozhu Zuo (4 shared papers)
- Journals
- Nature Communications (2 papers)Frontiers in Molecular Neuroscience (1 paper)Journal of Orthopaedic Translation (1 paper)Cellular Oncology (1 paper)Theranostics (1 paper)
- Partner nations
- ChinaNetherlandsGermany
In The Last Decade
Botai Li
10 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 799
- Molecular Biology 968
- Immunology 54
- Pulmonary and Respiratory Medicine 79
- Pathology and Forensic Medicine 38
Countries citing papers authored by Botai Li
This map shows the geographic impact of Botai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Botai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Botai Li more than expected).
Fields of papers citing papers by Botai Li
This network shows the impact of papers produced by Botai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Botai Li. The network helps show where Botai Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Botai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity Hit paper breakdown → | 2021 | 416 |
| 2 | 2019 | 284 | |
| 3 | 2018 | 152 | |
| 4 | 2020 | 115 | |
| 5 | 2020 | 41 | |
| 6 | 2019 | 37 | |
| 7 | 2023 | 6 | |
| 8 | 2024 | 5 | |
| 9 | 2022 | 2 | |
| 10 | 2024 | 1 |
About Botai Li
Botai Li is a scholar working on Molecular Biology, Cancer Research, Physiology, Surgery and Pharmacology, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), ATP Synthase and ATPases Research (2 papers), Steroid Chemistry and Biochemistry (1 paper) and Apelin-related biomedical research (1 paper). The work is most often cited by research in Cancer Research (799 citations), Molecular Biology (968 citations), Immunology (54 citations), Pulmonary and Respiratory Medicine (79 citations) and Pathology and Forensic Medicine (38 citations). Botai Li has collaborated with scholars based in China, Netherlands and Germany. Frequent co-authors include Haojie Jin, Chengtao Yu, Wenxin Qin, Zhuoan Cheng, Chen Yang, Siying Wang, Yuanyuan Lv, Qiaozhu Zuo, Cun Wang and Liyan Jiang. Their work appears in journals such as Nature Communications, Frontiers in Molecular Neuroscience, Journal of Orthopaedic Translation, Cellular Oncology and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.